Article
Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes.
Diabetes care - 1 Jun 2011
Ryhänen Samppa J, Härkönen Taina, Siljander Heli, Näntö-Salonen Kirsti, Simell Tuula, Hyöty Heikki, Ilonen Jorma, Veijola Riitta, Simell Olli, Knip Mikael
Abstract excerpt
OBJECTIVE: Despite promising results from studies on mouse models, intranasal insulin failed to prevent or delay the development of type 1 diabetes in autoantibody-positive children with HLA-conferred disease susceptibility. To analyze whether the insulin dose was inadequate to elicit an immunomodulatory response, we compared the changes observed in insulin antibody (IA) affinity and isotypes after treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
